Harbour Trust & Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Buy
+692
New +$257K 0.03% 137
2025
Q1
Sell
-1,044
Closed -$385K 156
2024
Q4
$385K Buy
1,044
+315
+43% +$132K 0.04% 122
2024
Q3
$379K Hold
729
0.04% 123
2024
Q2
$395K Sell
729
-40
-5% -$21.1K 0.05% 122
2024
Q1
$399K Hold
769
0.05% 129
2023
Q4
$363K Buy
+769
New +$356K 0.05% 133

Other funds holding ELV

Harbour Trust & Investment Management's ELV Position: Q2 2026 in Review

Harbour Trust & Investment Management opened a new position in Elevance Health (ELV) in Q2 2026: 692 shares worth $268K. The stake represents 0.03% of the portfolio and ranks #137 among its holdings. This is a return to the name: Harbour Trust & Investment Management previously reported a position in ELV as recently as Q4 2024.

Harbour Trust & Investment Management first reported a position in ELV in Q4 2023 and has held it in 6 quarters since. The position peaked at $399K in Q1 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Harbour Trust & Investment Management held 692 shares of Elevance Health worth $268K as of Q2 2026.
  • Elevance Health was a new Harbour Trust & Investment Management position in Q2 2026.
  • Elevance Health made up 0.03% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #137 holding.
  • Harbour Trust & Investment Management first reported a position in Elevance Health in Q4 2023 and has held it in 6 quarters since.
  • Harbour Trust & Investment Management's Elevance Health position peaked at $399K in Q1 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.